Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Population Diagnostics, Inc. Company Profile

20:41 EDT 23rd April 2014 | BioPortfolio

Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medicine tests. PDx’s technology, which reveals the genetic causes of complex diseases such as autism, diabetes, Parkinson’s, and Alzheimer’s, enables development of early detection diagnostic tests that predict pre-symptomatically why some individuals will suffer from debilitating diseases while others will not. When applied to drug discovery, the technology enables pharmaceutical companies to develop targeted therapies and companion diagnostics. Its novel technology and exclusive products places PDx in a prime position to (i) transform how physicians diagnose and manage disease in their patients and (ii) enable pharmaceutical companies to expand the number of available therapies and market drugs with higher efficacy and safety.


News Articles [687 Associated News Articles listed on BioPortfolio]

Parkinson's Institute, Population Diagnostics discover new genes relevant to Parkinson's disease

The Parkinson's Institute and Clinical Center announced today that they, in partnership with Population Diagnostics, Inc., have discovered a number of new genes relevant to the cause of Parkinson's di...

Qiagen, Exosome Diagnostics to develop diagnostics for cancer

Qiagen, a Netherlands-based holding company, has expanded its strategic partnership with Exosome Diagnostics to develop a first-in-class, non-invasive molecular in-vitro diagnostics for use in diagnos...

Population Genetics Licenses VeriTag™ Patent to Agilent Technologies

Population Genetics Technologies Ltd (PGT) has exclusively licensed patent rights including US 8,481,292 covering its VeriTag™ technology to Agilent Technologies. PGT retains ex...

Qiagen, Exosome Diagnostics expand partnership to develop diagnostics for lung cancer

Netherlands-based Qgen and US-based Exosome Diagnostics have announced an expansion of their strategic partnership for developing non-invasive molecular in-vitro diagnostics for key genetic biomarkers...

Companion Diagnostics - Streamlining drug development and advancing personalized medicine

Recently added to the BioPortfolio report store, Companion Diagnostics - Streamlining drug development and advancing personalized medicine is a new report from CBR Pharma Insights published on 2013-0...

EKF Molecular Diagnostics to exhibit PointMan DNA-enrichment technology at Tri-Con 2014

EKF Diagnostics, the global in vitro diagnostics business, announces that its subsidiary company EKF Molecular Diagnostics is exhibiting its ground-breaking PointMan DNA-enrichment technology at Tri-C...

MGC Diagnostics to acquire Medisoft

MGC Diagnostics, a global medical technologies company, has entered into a letter of intent to acquire Medisoft of Sorinnes, Belgium. MGC Diagnostics would acquire all the outstanding shares of Mediso...

Gear up for diagnostics

Epistem has appointed Dr. Allan Brown as Chief Operation Officer of their Diagnostics division. With the appointment, Manchester-based Epistem reacts to the increasing influence of diagnostics and per...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1215 Associated PubMed Articles listed on BioPortfolio]

Point-of-Care Diagnostics in Low-Resource Settings and Their Impact on Care in the Age of the Noncommunicable and Chronic Disease Epidemic.

The emergence of point-of-care (POC) diagnostics specifically designed for low-resource settings coupled with the rapid increase in need for routine care of patients with chronic diseases should promp...

The difficulties encountered in diagnostics of malignant neoplasms of the middle ear in the children.

The objective of the present work was to estimate the potential of CT and MRI diagnostics of malignant neoplasms of the middle ear in the children. Diagnostics of these tumours encounters great diffic...

Structured diagnostics and therapy of the CUP syndrome.

In the majority of cases, patients with cancer of unknown primary (CUP) have a poor prognosis with no prospect of being cured. Hence, a reasonable focus of diagnostics on its essential targets seems a...

Integrating molecular diagnostics into histopathology training: the Belfast model.

Molecular medicine is transforming modern clinical practice, from diagnostics to therapeutics. Discoveries in research are being incorporated into the clinical setting with increasing rapidity. This t...

Patella dislocation: an algorithm for diagnostic and treatment considering the rotation.

Background: Patella dislocation and re-dislocation are common diseases. Although patella dislocation is frequent, it always poses a challenge concerning diagnostics and therapy. Mixed forms of patholo...

Clinical Trials [849 Associated Clinical Trials listed on BioPortfolio]

BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes

Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include autom...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of...

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Implementation of Quality of Life Diagnostics and Therapy

Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics...

Clinical Sensitivity of Clearview Rapid Tests in 12-17 y/o Pediatric Population

This study is to establish the clinical sensitivity of the Chembio Diagnostics Systems, Inc. Clearview COMPLETE HIV 1/2 Assay and Clearview HIV 1/2 Stat-Pak Assay (Clearview HIV tests) in...

Companies [1026 Associated Companies listed on BioPortfolio]

Population Genetics Technologies Ltd

Population Genetics Technologies Ltd was founded in 2005 by Nobel Laureate Dr Sydney Brenner; by Dr Sam Eletr, a founder of Applied Biosystems and of Lynx Therapeutics; and by Dr...

Veterinary Diagnostics Institute (VDxI), Inc.

VDxI, a California corporation, is a veterinary clinical ventures company dedicated to the introduction of innovative biomarkers for companion animals. Through collaboration with...

Population Diagnostics, Inc.

Population Diagnostics, Inc. (PDx, www.populationdiagnostics.com) is applying its discoveries in human genetics to the development of DNA-based diagnostics and personalized medici...

Quintiles and Population Genetics Technologies Ltd.

Co-founded by Nobel Laureate Dr. Sydney Brenner, Population Genetics Technologies creates products that accelerate large-scale population studies, through the simultaneous analysi...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices...

More Information about "Population Diagnostics, Inc." on BioPortfolio

We have published hundreds of Population Diagnostics, Inc. news stories on BioPortfolio along with dozens of Population Diagnostics, Inc. Clinical Trials and PubMed Articles about Population Diagnostics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Population Diagnostics, Inc. Companies in our database. You can also find out about relevant Population Diagnostics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement